Results of transsphenoidal surgery in a large series of patients with pituitary adenoma

Neurosurgery

Volumn 56, Issue 6, 2005, Pages 1222-1233

  Mortini, Pietro ^a,b   Losa, Marco ^a   Barzaghi, Raffaella ^a   Boari, Nicola ^a   Giovanelli, Massimo ^a  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Pituitary adenoma; Transsphenoidal surgery

Indexed keywords

CORTICOTROPIN; DOPAMINE RECEPTOR STIMULATING AGENT; GROWTH HORMONE; HYDROCORTISONE; METHYLPREDNISOLONE; POTASSIUM ION; PROLACTIN; SODIUM ION; THYROTROPIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CAVERNOUS SINUS; FEMALE; GROWTH HORMONE RELEASE; HUMAN; HYPOPHYSIS ADENOMA; MAJOR CLINICAL STUDY; MALE; MICROSURGERY; POPULATION RESEARCH; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROLACTINOMA; REMISSION; SCHOOL CHILD; STEREOTAXIC SURGERY; SURGICAL RISK; SURGICAL TECHNIQUE; TRANSSPHENOIDAL SURGERY; TREATMENT OUTCOME; VISUAL DISORDER;

ADENOMA; ADULT; FEMALE; HUMANS; HYPOPHYSECTOMY; MALE; MIDDLE AGED; PITUITARY HORMONES; PITUITARY NEOPLASMS; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; SPHENOID SINUS; TREATMENT OUTCOME; VISION DISORDERS;

EID: 20044372351     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/01.NEU.0000159647.64275.9D     Document Type: Article

References (77)

1. Abosch A, Tyrrell JB, Lamborn KR, Hannegan LT, Applebury CB, Wilson CB: Transsphenoidal microsurgery for growth hormone-secreting pituitary adenomas: Initial outcome and long-term results. J Clin Endocrinol Metab 83:3411-3418, 1998.
2. Ahmed S, Elsheikh M, Straften IM, Page RC, Adams CB, Wass JA: Outcome of transsphenoidal surgery for acromegaly and its relationship to surgical experience. Clin Endocrinol 50:561-567, 1999.
3. Arafah BM, Rosenzweig JL, Fenstermaker R, Salazar R, McBride CE, Selman WR: Value of growth hormone dynamics and somatomedin C (insulin-like growth factor I) levels in predicting the long-term benefit after transsphenoidal surgery for acromegaly. J Lab Clin Med 109:346-354, 1987.
4. Bevan JS, Adams CB, Burke CW, Morton KE, Molyneux AJ, Moore RA, Esiri MM: Factors in the outcome of transsphenoidal surgery for prolactinoma and non-functioning pituitary tumour, including pre-operative bromocriptine therapy. Clin Endocrinol 26:5415-5456, 1987.
5. Biermasz NR, Van Dulken H, Roelfsema F: Ten-year follow-up results of transsphenoidal microsurgery in acromegaly. J Clin Endocrinol Metab 85:2476-2482, 2000.
6. Black PMcL, Zervas NT, Candia GL: Incidence and management of complications of transsphenoidal operation for pituitary adenoma. Neurosurgery 20:920-924, 1987.
7. Bochicchio D, Losa M, Buchfelder M: Factors influencing the immediate and late outcome of Cushing's disease treated by transsphenoidal surgery: A retrospective study by the European Cushing's Disease Survey Group. J Clin Endocrinol Metab 80:3114-3120, 1995.
8. Buchfelder M, Fahlbusch R: Komplikationen bei Operationen von Hypophysenadenomen, in Bock WJ, Schirmer M (eds): Komplikationen bei neurochirurgischen Eingriffen. München, Zuckschwerdt, 1988, pp 18-32.
9. Buchfelder M, Fahlbusch R: Risiken und Komplikationen bei Operationen von Prozessen im Sellabereich. Nervenheilkunde 11:105-111, 1992.
10. Buchfelder M, Brockmeier S, Fahlbusch R, Honegger J, Pichl J, Manzl M: Recurrence following transsphenoidal surgery for acromegaly. Horm Res 35:113-118, 1991.
11. Burke CW, Adams CBT, Esiri MM, Morris C, Bevan JS: Transsphenoidal surgery for Cushing's disease: Does what is removed determine the endocrine outcome? Clin Endocrinol (Oxf) 33:525-537, 1990.
12. Cappabianca P, Cavallo LM, Colao A, de Divitiis E: Surgical complications associated with the endoscopic endonasal transsphenoidal approach for pituitary adenomas. J Neurosurg 97:293-298, 2002.
13. Ciric I, Ragin A, Baumgartner C, Pierce D: Complications of transsphenoidal surgery: Results of a national survey, review of the literature, and personal experience. Neurosurgery 40:225-236, 1997.
14. Clayton RN: How many surgeons to operate an acromegalic patient? Clin Endocrinol 50:557-559, 1999.
15. Ebersold MJ, Quast LM, Laws ER Jr, Scheithauer B, Randall RV: Long-term results in transsphenoidal removal of nonfunctioning pituitary adenomas. J Neurosurg 64:713-719, 1986.
16. Fahlbusch R, Stass P: Pituitary adenomata: Status of diagnosis and therapy [in German]. MMW Münch Med Wochenschr 123:549-555, 1981.
17. Fahlbusch R, Buchfelder M, Müller OA: Transsphenoidal surgery for Cushing's disease. J R Soc Med 79:262-269, 1986.
18. Fahlbusch R, Honegger J, Buchfelder M: Surgical management of acromegaly. Endocrinol Metab Clin North Am 21:669-692, 1992.
19. Feigenbaum SL, Downey DE, Wilson CB, Jaffe RB: Transsphenoidal pituitary resection for preoperative diagnosis of prolactin-secreting pituitary adenoma in women: Long term follow-up. J Clin Endocrinol Metab 81: 1711-1719, 1996.
20. Feigl GC, Bonelli CM, Berghold A, Mokry M: Effects of gamma knife radiosurgery of pituitary adenomas on pituitary function. J Neurosurg 97:415-421, 2002.
21. Freda PU, Wardlaw SL: Clinical review 110: Diagnosis and treatment of pituitary tumors. J Clin Endocrinol Metab 84:3859-3866, 1999.
22. Freda PU, Wardlaw SL, Post KD: Long-term endocrinological follow-up evaluation in 115 patients who underwent transsphenoidal surgery for acromegaly. J Neurosurg 89:353-358, 1998.
23. Giovanelli M, Losa M, Baiguini M, Motti E, Ducati A: Transcranial versus transsphenoidal approach in the surgical treatment of pituitary adenomas, in Faglia G, Beck-Peccoz P, Ambrosi B, Travaglini P, Spada A (eds): Pituitary Adenomas: New Trends in Basic and Clinical Research. Amsterdam, Excerpta Medica, 1991, pp 313-320.
24. Gittoes NJ, Sheppard MC, Johnson AP, Stewart PM: Outcome of surgery for acromegaly: The experience of a dedicated pituitary surgeon. Q J Med 92:741-745, 1999.
25. Giustina A, Barkan A, Casanueva FF, Cavagnini F, Frohman L, Ho K, Veldhuis J, Wass J, Von Werder K, Melmed S: Criteria for cure of acromegaly: A consensus statement. J Clin Endocrinol Metab 85:526-529, 2000.
26. Guilhaume B, Bertagna X, Thomsen M, Bricaire C, Vila-Porcile E, Olivier L, Racadot J, Derome P, Laudat MH, Girard F: Transsphenoidal pituitary surgery for the treatment of Cushing's disease: Results in 64 patients and long term follow-up studies. J Clin Endocrinol Metab 66:1056-1064, 1988.
27. Guiot G, Derome P: Surgical problems of pituitary adenomas, in Krayenbühl H (ed): Advances and Technical Standards in Neurosurgery. Wien, Springer Velag, 1976, pp 3-33.
28. Hardy J: Cushing's disease: 50 years later. Can J Neurol Sci 9:375-380, 1982.
29. Hardy J: Trans-sphenoidal approach to the pituitary gland, in Wilkins RH, Rengachary SS (eds): Neurosurgery. New York, McGraw-Hill, 1996, pp 1375-1384.
30. Hardy J, Mohr G: Prolactinoma: Surgical aspects [in French]. Neurochirurgie 27[Suppl 1]:41-60, 1981.
31. Kaltsas GA, Isidori AM, Florakis D, Trainer PJ, Camacho-Hubner C, Afshar F, Sabin I, Jenkins P, Chew SL, Monson JP, Besser GM, Grossman AB: Predictors of the outcome of surgical treatment in the acromegaly and the value of the mean growth hormone day curve in assessing postoperative disease activity. J Clin Endocrinol Metab 86:1645-1652, 2001.
32. Kautzy R, Lüdecke D, Nowakowski H: Transsphenoidal operation in acromegaly, in Fahlbusch R, Von Werder K (eds): Treatment of Pituitary Adenomas. Stuttgart, Georg Thieme Verlag, 1978, pp 219-225.
33. Knappe UJ, Lüdecke D: Persistent and recurrent hypercortisolism after transsphenoidal surgery for Cushing's disease. Acta Neurochir Suppl (Wien) 65:31-34, 1995.
34. Knosp E, Steiner E, Kitz K, Matula C: Pituitary adenomas with invasion of the cavernous sinus space: Magnetic resonance imaging classification compared with surgical findings. Neurosurgery 33:610-617, 1993.
35. Kreutzer J, Vance ML, Loper BS, Laws ER Jr: Surgical management of GH-secreting pituitary adenomas: An outcome study using modern remission criteria. J Clin Endocrinol Metab 86:4072-4077, 2001.
36. Laws ER Jr: Complications of transsphenoidal microsurgery for pituitary adenomas, in Brock M (ed): Modern Neurosurgery. Berlin, Springer Velag, 1982, vol 1, pp 181-186.
37. Littley MD, Shalet SM, Beardwell CG, Ahmed SR, Applegate G, Sutton ML: Hypopituitarism following external radiotherapy for pituitary tumors in adults. Q J Med 70:145-160, 1989.
38. Losa M, Barzaghi R, Mortini P, Franzin A, Mangili F, Terreni MR, Giovanelli M: Determination of the proliferation and apoptotic index in adrenocorticotropin-secreting pituitary tumors: Comparison between micro- and macroadenomas. Am J Pathol 156:245-251, 2000.
39. Losa M, Giovanelli M, Persani L, Mortini P, Faglia G, Beck-Peccoz P: Criteria of cure and follow-up of central hyperthyroidism due to thyrotropin-secreting pituitary adenomas. J Clin Endocrinol Metab 81:3084-3090, 1996
40. Maira G, Anile C, De Marinis L, Barbarino A: Prolactin-secreting adenomas: Surgical results and long-term follow-up. Neurosurgery 24:736-743, 1989.
41. Mampalam TJ, Tyrrell JB, Wilson CB: Transsphenoidal microsurgery for Cushing's disease: A report of 216 cases. Ann Intern Med 109:487-493, 1988.
42. Mangram AJ, Horam TC, Pearson ML, Silver LC, Jarvis WR: Guideline for prevention of surgical site infection, 1999: Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol 20:250-280, 1999.
43. Marazuela M, Astigarraga B, Vicente A, Estrada J, Cuerda C, Garcia-Uria J, Lucas T: Recovery of visual and endocrine function following transsphenoidal surgery of large nonfunctioning pituitary adenomas. J Endocrinol Invest 17:703-707, 1994.
44. Massoud F, Serri O, Hardy J, Somma M, Beauregard H: Transsphenoidal adenomectomy for microprolactinomas: 10 to 20 yr of follow-up. Surg Neurol 45:341-346, 1996.
45. McCance DR, Besser M, Atkinson AB: Assessment of cure after transsphenoidal surgery for Cushing's disease. Clin Endocrinol 44:1-6, 1996.
46. Mindermann T, Wilson CB: Thyrotropin-producing pituitary adenomas. J Neurosurg 79:521-527, 1993
47. Molitch ME: Medical treatment of prolactinomas. Endocrinol Metab Clin North Am 28:143-169, 1999.
48. Nakane T, Kuwayama A, Watanabe M, Takahashi T, Kato T, Ichihara K, Kageyama N: Long term results of transsphenoidal adenomectomy in patients with Cushing's disease. Neurosurgery 21:218-222, 1987.
49. Nelson PB, Goodman M, Maroon JC, Martinez AJ, Moossy J, Robinson AG: Factors in predicting outcome from operation in patients with prolactin-secreting pituitary adenomas. Neurosurgery 13:634-641, 1983.
50. Nicola GC, Tonnarelli GP, Griner AC: Complications of transsphenoidal surgery in pituitary adenomas, in Derome PJ, Jedynak CP, Peillon F (eds): Pituitary Adenomas. Paris, Asclepios Publishers, 1980, pp 237-240.
51. Onesti ST, Post KD: Complications of transsphenoidal microsurgery, in Onesti ST, Post KD, Friedman ED, McCormick P (eds): Postoperative Complications in Intracranial Neurosurgery. New York, Thieme, 1993, pp 61-73.
52. Otten P, Rilliet B, Reverdin A, Demierre B, Berney J: Pituitary adenoma secreting prolactin: Results of their surgical treatment [in French]. Neurochirurgie 42:44-53, 1996.
53. Ozgen T, Oruckaptan HH, Ozcan OE, Acikgoz B: Prolactin secreting pituitary adenomas: Analysis of 429 surgically treated patients, effect of adjuvant treatment modalities and review of the literature. Acta Neurochir (Wien) 141:1287-1294, 1999.
54. Quabbe HJ: Treatment of acromegaly by trans-sphenoidal operation, 90-yttrium implantation and bromocriptine: Results in, 230 patients. Clin Endocrinol 16:107-119, 1982.
55. Rawe SE, Williamson HO, Levine JH, Phansey SA, Hungerford D, Adkins WY: Prolactinomas: Surgical therapy, indications and results. Surg Neurol 80:161-167, 1980.
56. Rees DA, Hanna FW, Davies JS, Mills RG, Vafidis J, Scanlon MF: Long-term follow-up results of transsphenoidal surgery for Cushing's disease in a single centre using strict criteria for remission. Clin Endocrinol 56:541-251, 2002.
57. Robert F, Hardy J: Cushing's disease: A correlation of radiological, surgical and pathological findings with therapeutic results. Pathol Res Pract 187: 617-621, 1991.
58. Rodman EF, Molitch ME, Post KD, Biller BJ, Reichlin S: Long-term follow-up of transsphenoidal selective adenomectomy for prolactinoma. JAMA 252: 921-924, 1984.
59. Rush S, Cooper PR: Symptom resolution, tumor control, and side effects following postoperative radiotherapy for pituitary macroadenomas. Int J Radiat Oncol Biol Phys 37:1031-1034, 1997.
60. Salmi J, Grahne B, Valtonen S, Pelkonen R: Recurrence of chromophobe pituitary adenomas after operation and postoperative radiotherapy. Acta Neurol Scand 66:681-689, 1982.
61. Scanlon MF, Peters JR, Thomas JP, Richards SH, Morton WH, Howell S, Williams ED, Hourihan M, Hall R: Management of selected patients with hyperprolactinemia by partial hypophysectomy. Br Med J 291:1547-1550, 1985.
62. Schlechte JA, Sherman BM, Chapler FK, Van Gilder J: Long term follow-up of women with surgically treated prolactin-secreting pituitary tumors. J Clin Endocrinol Metab 62:1296-1301, 1986.
63. Schwartz M, Swearingen B, Black PMcL: Transsphenoidal surgery for pituitary tumors, in Kaye AH, Black PMcL (eds): Operative Neurosurgery. London, Churchill Livingstone, 2000, pp 672-683.
64. Serri O, Rasio E, Beauregard H, Hardy J, Somma M: Recurrence of hyperprolactinemia after selective adenomectomy in women with prolactinomas. N Engl J Med 309:280-283, 1983.
65. Shimon I, Cohen ZR, Ram Z, Hadani M: Transsphenoidal surgery for acromegaly: Endocrinological follow-up of 98 patients. Neurosurgery 48: 1239-1245, 2001.
66. Shimon I, Ram Z, Cohen ZR, Hadani M: Transsphenoidal surgery for Cushing's disease: Endocrinological follow-up monitoring of 82 patients. Neurosurgery 51:57-61, 2002.
67. Shone GR, Richards SH, Hourihan MD, Hall R, Thomas JP, Scanlon MF: Non-secretory adenomas of the pituitary treated by trans-ethmoidal sellotomy. J R Soc Med 84:140-143, 1991.
68. Snyder PJ, Fouble BF, Schwartz NJ, Savina PJ, Gennarelli TH: Hypopituitarism following radiation therapy of pituitary adenomas. Am J Med 81:457-462, 1986.
69. Stevenaert A, Perrin G, Martin D, Beckers A: Cushing's disease and corticotrophic adenoma: Results of pituitary microsurgery [in French]. Neurochirurgie 48:234-265, 2002.
70. Swearingen B, Biller BM, Barker FG II, Katznelson L, Grinspoon S, Klibanski A, Zervas NT: Long-term mortality after transsphenoidal surgery for Cushing's disease. Ann Intern Med 130:821-824, 1999.
71. Tindall GT, Barrow DL: Pituitary surgery, in Disorders of the Pituitary. St Louis, C.V. Mosby, 1986, pp 349-400.
72. Tindall GT, Herring CJ, Clark RV, Adams DA, Watts NB: Cushing's disease: Results of transsphenoidal microsurgery with emphasis on surgical failures. J Neurosurg 72:363-369, 1990.
73. Tindall GT, Woodard EJ, Barrow DL: Pituitary adenomas: General considerations, in Apuzzo MLJ (ed): Brain Surgery. New York, Churchill Livingstone, 1993, pp 269-276.
74. Trainer PJ, Lawrie HS, Verfielst J, Hewlett TA, Lowe DG, Grossman AB, Savage MO, Afshar F, Besser GM: Transsphenoidal resection in Cushing's disease: Undetectable serum cortisol as the definition of successful treatment. Clin Endocrinol 38:73-78, 1993.
75. Tyrrell JB, Lanborn KR, Hannegan LT, Applebury CB, Wilson CB: Transsphenoidal microsurgical therapy of prolactinomas: Initial outcomes and long-term results. Neurosurgery 44:254-263, 1999.
76. Von Werder K, Eversmann T, Fahlbusch R: Endocrine-active pituitary adenomas: Long-term results of medical and surgical treatment, in Camanni F, Müller EE (eds): Pituitary Hyperfunction: Physiopathology and Clinical Aspects. New York, Raven Press, 1984, pp 385-406.
77. Wilson CB, Dempsey LC: Transsphenoidal microsurgical removal of 250 pituitary adenomas. J Neurosurg 48:13-22, 1978.